Marie Antoinette’s quote is a great reminder that at times, new uses can be found with old things, such is the case with the drug Naltrexone. First synthesized as a competitive opioid antagonist in 1963, for many years research on Naltrexone remained dormant until
More than half of all people with thyroid disease are unaware of their condition. Many patients have tried synthetic thyroid hormones, such as levothyroxine and liothyronine, and have found that Natural Thyroid is the only form that works adequately for them, reporting that they simply do not feel as well when they take levothyroxine alone or with liothyronine. Currently, certain forms and strengths of Natural Thyroid are available only through compounding pharmacies.
Coming up with new drug delivery techniques that can precisely target cancer cells, while leaving healthy tissue unharmed, has been a major goal for cancer researchers in recent years. Scientists at the University of Manchester have been testing a new approach that relies on liposomes. The new studies demonstrate for the first time how they can be built to include a temperature control, which could be an effective way of targeting treatment towards cancer cells while leaving healthy cells unharmed.
The world is facing the threat of ‘superbugs’ as these bacteria dubbed as methicillin-resistant Staphylococcus aureus (MRSA) have evolved into one of the most difficult-to-treat pathogens. MRSA is a bacteria that is resistant to many antibiotics. In the external community, most MRSA infections are skin infections. In medical facilities, MRSA causes life-threatening bloodstream infections, pneumonia and surgical site infections. A new study suggests that treatment with the wrong antibiotic could make MRSA-induced infections worse.
Researchers reported the first evidence that a new class of drugs known to dramatically lower cholesterol may also reduce risk of heart attacks, strokes and other serious consequences of cardiovascular disease. The drugs represent the most important new class of cholesterol-lowering medications since the first statin was approved in 1987.
